What areas can be treated with Renuvion
Ozempic and Tirzepatide (Mounjaro) are primarily approved for type 2 diabetes management, but recent research highlights their potential benefits for non-diabetic individuals, particularly in weight management
In addition, when circulating L-carnitine concentration increases, as in the case of oral supplementation, renal reabsorption of L-carnitine may become saturated, resulting in increased urinary excretion of L-carnitine (5)
In some cases, high-dose daily oral B12 supplements (typically 1000 g daily) can also be used as an effective alternative or addition for maintenance therapy [9] [10]
Doss GA, Baillie TA
Why We Need to Change the Way We Talk About GLP-1 Medications After talking with Summer, it really solidified the fact that we need to approach the topic of GLP-1s and obesity with more nuance and less judgement in our society